Sangamo Therapeutics (SGMOQ) Deferred Taxes (2015 - 2025)

Sangamo Therapeutics' Deferred Taxes history runs 5 years deep, the most recent figure standing at $15000.0 for Q1 2025.

• On a quarterly basis, Deferred Taxes changed N/A year-over-year to $15000.0 in Q1 2025; TTM through Mar 2025 was $15000.0, a 64.29% decrease from a year earlier, with the FY2023 full-year figure at -$6.3 million, changed N/A from the prior year.
• Deferred Taxes climbed to $15000.0 in Q1 2025 per SGMOQ's latest filing, from -$18000.0 in the prior quarter.
• Across five years, Deferred Taxes topped out at $182000.0 in Q3 2023 and bottomed at -$140000.0 in Q4 2023.
• The 3-year median for Deferred Taxes is $15000.0 (2025), against an average of $11400.0.
• Biggest YoY gain for Deferred Taxes was 87.14% in 2024; the steepest drop was 90.11% in 2024.
• Year by year, Deferred Taxes stood at -$140000.0 in 2023, then surged by 87.14% to -$18000.0 in 2024, then surged by 183.33% to $15000.0 in 2025.
• Per Business Quant, the three latest SGMOQ Deferred Taxes figures stand at $15000.0 (Q1 2025), -$18000.0 (Q4 2024), and $18000.0 (Q3 2024).